Study on the efficacy of LED phototherapy in patients with seasonal allergic rhinitis

Tanigawa Takeshi0 个研究点目标入组 22 人开始时间: 2022年12月22日最近更新: 2024年4月1日

适应症

试验速览

暂无简介。

•1) Men and women between the ages of 18 and 50 years old at the time of informed consent
•2) Patients diagnosed with allergic rhinitis
•3) Patients with cedar-specific IgE antibodies
•4) Patients who have start the treatment of allergic rhinitis
•5) Patients who are able to visit Juntendo Hospital or Hongo Otorhinolaryngology Clinic
•6) Patients who have given a full explanation of their participation in this study and who have given written consent of their own free will.

•1) Patients undergoing treatment for or with a history of peripheral neuropathy or photosensitivity
•2) Patients who are being treated for or have a history of mental illness, stroke, or myocardial infarction
•3) Patients who are pregnant or planning to become pregnant during the study period
•4) Patients who are using steroids (oral or injectable) or biological agents for the treatment of allergic rhinits
•5) Patients who started taking allergic rhinitis medication or who have changed or added to their medication within 4 weeks prior to the start of the intervention.
•6) Any other Patients who is deemed by the physician to be ineligible to participate in the study.

发起方

Tanigawa Takeshi